Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPO13 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
mRNA | C10orf35 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
mRNA | NGEF | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
mRNA | AC003005.4 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | PDCD6IP | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | NUDT6 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | TMEM258 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
mRNA | PSMG1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | NABP2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
mRNA | LRRC63 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |